Good News | Lepu CRRT Dialyzer Has Received NMPA Registration

Investors
LEPU Medical
EN
LEPU Medical
EN JP FR DE ES IT RU PT TR PL ID AR KO
Products
Cardiovascular & Peripheral Products In Vitro Diagnosis Structural Heart Diseases Products Critical Care Products Hemodialysis Products ECG & Patient Monitor & Telehealth Solutions Pharmaceutical (API) Products Surgical Products Orthopedic Products Cardiac Rhythm Management Products Innovative Medicines Digital Subtraction Angiography Systems
Solutions
PCI Solution Hemodialysis Solution Orthopedic and Surgical In-Hospital and Out-of-Hospital Solution
Services
About Us
Join us
IFU
News
News Customer Stories PR
Investor
Contact Us
LEPU Medical
LEPU Medical
Home>News

Good News | Lepu CRRT Dialyzer Has Received NMPA Registration

2026-11-04
LEPU Medical
Good News | Lepu CRRT Dialyzer Has Received NMPA Registration

We are proud to announce that our dialyzer for Continuous Renal Replacement Therapy (CRRT) has officially obtained registration approval from China's National Medical Products Administration (NMPA).


This approval means far more than a certificate — it marks a strategic leap for us: from Hemodialysis (HD) to the CRRT space. It is a clear testament to our R&D strength and our ability to translate complex clinical needs into reliable, high-quality products.


We will continue to deepen our roots in the blood purification field and develop more products that meet real clinical needs.




Good News | Lepu CRRT Dialyzer Has Received NMPA Registration


LEPU Medical
Submit